Ilypsa

Develops phosphate and potassium binder compounds to treat chronic kidney diseases

placeSanta Clara, California, United States calendar_todayFounded 2002 groups79 employees language ilypsa.com

Innovation

31 patent families (13 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 2,883 times.

YearFilings
20124
20136
20143
20153
20163
20174
20183
20192
20202
20212

Investor mix

9 investors on record.

Investor typeCountShare
Venture capital889%
Bank & private debt111%
Coming soon